Forecast

Buy	0
Hold	5
Sell	0

News Go to news feed

Silverback Therapeutics hits 52-week high after strong price surge

Shares of Silverback Therapeutics reached a new 52-week high at $18.59, marking a year-over-year increase of 112.46%. The biotechnology company is benefiting from investor optimism, progress in its clinical pipeline, and a solid financial position. Analysts see further upside potential, while the company's market capitalization now stands at $1.81 billion. » More on de.investing.com
Safety Shot completes acquisition of Yerbae Brands and expands product portfolio

Safety Shot, Inc. has completed the acquisition of Yerbae Brands Corp. through a court-approved plan of arrangement. Following the transaction, Safety Shot shareholders hold approximately 81.64% and former Yerbae shareholders about 18.36% of the merged company. Safety Shot also plans to expand its product portfolio to include nootropics and sleep aids, and has entered into a debt settlement agreement with Silverback Capital Corporation. » More on de.investing.com

Financials

In the last quarter, SILVERBACK THERAP. -,0001 Aktie had revenue of €29.49M and net profit of -€54.62M

(EUR)	Jun 2026	YoY
Revenue	29.49M	121.16%
Gross profit	0	-
Net profit	-54.62M	43.44%
EBITDA	-53.86M	42.32%

Fundamentals

Metric	Value
Market capitalization	€475.21M
Number of shares	93.77M
52-week high/low	€6.51 - €2.42
Dividends	No
Beta	0.00
P/E ratio	-2.70
PEG ratio	0.03
P/B ratio	46.75
P/S ratio	5.00

Company profile

Silverback Therapeutics, Inc. ist ein biopharmazeutisches Unternehmen, das gewebebezogene Therapeutika für die Behandlung von chronischen Virusinfektionen, Krebs und anderen schweren Krankheiten entwickelt. Das Unternehmen bietet SBT8230 zur Behandlung chronischer Hepatitis-B-Virusinfektionen an, indem es eine antivirale Immunantwort durch gezielte TLR8-Aktivierung in der Leber auslöst. Silverback Therapeutics, Inc. wurde im Jahr 2016 gegründet und hat seinen Hauptsitz in Seattle, Washington.

Name	SILVERBACK THERAP. -,0001 Aktie
CEO	Peter A. Thompson
Headquarters	Seattle, wa USA
Website	silverbacktx.com
Sector	Materials
Industry	Chemicals
IPO	12/03/2020
Employees	90